{
    "2018-07-20": [
        [
            {
                "time": "",
                "original_text": "恒瑞医药需重新估值 创新药子板块将上演“戴维斯双击”——专访雷球资产投资总监顾斌",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "重新估值",
                        "创新药",
                        "戴维斯双击",
                        "投资总监"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-20",
                "original_text": "今日近一年上市新股市场表现一览（2018年7月20日）",
                "features": {
                    "keywords": [
                        "新股",
                        "市场表现",
                        "2018年7月20日"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "均超一亿$！GEN：2018上半年IPO全球Top10，药明康德摘得榜首",
                "features": {
                    "keywords": [
                        "IPO",
                        "GEN",
                        "2018上半年",
                        "全球Top10",
                        "药明康德"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业黑天鹅频出 估值偏高下医药股还具投资价值?",
                "features": {
                    "keywords": [
                        "医药行业",
                        "黑天鹅",
                        "估值偏高",
                        "投资价值"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}